Linyong Du
- Molecular Biology top 10%
- Cancer Research top 2%
- Immunology top 5%
- Oncology top 10%
- Epidemiology
- Topics
- Cancer, Hypoxia, and Metabolism (7 papers)Immune Response and Inflammation (6 papers)Cytokine Signaling Pathways and Interactions (5 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Linyong Du
30 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 906
- Cancer Research 653
- Immunology 589
- Oncology 314
- Epidemiology 119
Countries citing papers authored by Linyong Du
This map shows the geographic impact of Linyong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linyong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linyong Du more than expected).
Fields of papers citing papers by Linyong Du
This network shows the impact of papers produced by Linyong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linyong Du. The network helps show where Linyong Du may publish in the future.
Co-authorship network of co-authors of Linyong Du
This figure shows the co-authorship network connecting the top 25 collaborators of Linyong Du. A scholar is included among the top collaborators of Linyong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linyong Du. Linyong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 40 | |
| 3 | 16 | |
| 4 | 5 | |
| 5 | 12 | |
| 6 | Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBαbreakdown → | 246 |
| 7 | 20 | |
| 8 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesisbreakdown → | 260 |
| 9 | 117 | |
| 10 | 144 | |
| 11 | 5 | |
| 12 | 11 | |
| 13 | 11 | |
| 14 | 42 | |
| 15 | 29 | |
| 16 | 26 | |
| 17 | 4 | |
| 18 | 25 | |
| 19 | 51 | |
| 20 | 114 |
About Linyong Du
Linyong Du is a scholar working on Cancer Research, Immunology and Immunology and Allergy, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Immune Response and Inflammation (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Cancer Research (653 citations), Immunology (589 citations) and Molecular Biology (906 citations). Linyong Du has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Zhimin Lu, Xu Qian, Daqian Xu, Yanhua Zheng, Anying Zhang, Xinjian Li, Hong Zhou, Dongming Xing, Yan Xia and Wei He. Their work appears in journals such as Nature, The Journal of Experimental Medicine and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.